GeoVax Labs Inc. (GOVX)

Last Closing Price: 1.91 (2026-11-19)

Company Description

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $2.49M
Net Income (Most Recent Fiscal Year) $-21.47M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.88
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -1010.68%
Return on Assets (Trailing 12 Months) -420.06%
Current Ratio (Most Recent Fiscal Quarter) 1.46
Quick Ratio (Most Recent Fiscal Quarter) 1.46
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $2.11
Earnings per Share (Most Recent Fiscal Quarter) $-10.56
Earnings per Share (Most Recent Fiscal Year) $-537.17
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 0.54M
Free Float 0.54M
Market Capitalization $1.08M
Average Volume (Last 20 Days) 0.43M
Beta (Past 60 Months) 3.85
Percentage Held By Insiders (Latest Annual Proxy Report) 0.22%
Percentage Held By Institutions (Latest 13F Reports) 6.09%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%